Novoprotein Scientific Inc. (SHA:688137)

Market Cap	2.94B +28.5%
Revenue (ttm)	151.51M +18.8%
Net Income	-76.18M
EPS	-1.09
Shares Out	69.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	601,705
Average Volume	715,086
Open	40.60
Previous Close	40.62
Day's Range	40.46 - 42.38
52-Week Range	28.67 - 54.56
Beta	1.81
RSI	44.61
Earnings Date	Apr 29, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular research and diagnosis, and virus-related products, including antigens, antibodies and test kits. The company also provides protein expression and puri...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 556
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688137

Financial Performance

In 2025, Novoprotein Scientific's revenue was 151.51 million, an increase of 18.78% compared to the previous year's 127.56 million. Losses were -76.18 million, 40.0% more than in 2024.